CIK 0001719714 · Non-accelerated filer<br>Smaller reporting company
Mereo BioPharma Group plc
Sign in to watch- Ticker
- MREO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 4403330237300
- Business address
- ONE CAVENDISH PLACE, FOURTH FLOOR, LONDON, United Kingdom, W1G 0QF
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-21 | Scots-Knight Denise Chief Executive Officer | Option exercise | +282,090 | 842,503 | ||
| 2024-06-21 | Scots-Knight Denise Chief Executive Officer | Option exercise · Performance Based Restricted Stock Unit | +282,090 | 188,060 | ||
| 2024-06-21 | Sermon Charles General Counsel | Option exercise | +98,400 | 230,776 | ||
| 2024-06-21 | Sermon Charles General Counsel | Option exercise · Performance Based Restricted Stock Unit | +98,400 | 65,600 | ||
| 2024-06-21 | Fox Christine Ann Chief Financial Officer | Option exercise | +90,000 | 100,000 | ||
| 2024-06-21 | Fox Christine Ann Chief Financial Officer | Option exercise · Performance Based Restricted Stock Unit | +90,000 | 60,000 | ||
| 2024-06-21 | Hughes-Wilson Alexandra See Remarks | Option exercise | +60,000 | 67,650 | ||
| 2024-06-21 | Hughes-Wilson Alexandra See Remarks | Option exercise · Performance Based Restricted Stock Unit | +60,000 | 40,000 | ||
| 2024-06-17 | Rubric Capital Management LP 10% owner | Grant or award · American Depositary Shares ("ADSs") | +1,754,350 | $3.99 | $7.0M | 15,307,347 |
| 2024-06-17 | WYZGA MICHAEL S Director | Grant or award | +25,050 | $3.99 | $100K | 25,050 |
| 2024-06-17 | Bender Jeremy Director | Grant or award | +12,550 | $3.99 | $50K | 12,550 |
| 2024-05-22 | Hughes-Wilson Alexandra See Remarks | Option exercise | +93,333 | $1.40 | $131K | 100,983 |
| 2024-05-22 | Hughes-Wilson Alexandra See Remarks | Sale | −50,350 | $2.99 | $151K | 58,633 |
| 2024-05-22 | Hughes-Wilson Alexandra See Remarks | Shares withheld for taxes | −42,983 | $1.40 | $60K | 7,650 |
| 2024-05-22 | Hughes-Wilson Alexandra See Remarks | Option exercise | +75,000 | $1.01 | $76K | 82,650 |
| 2024-05-22 | Hughes-Wilson Alexandra See Remarks | Sale | −50,082 | $2.94 | $147K | 32,568 |
| 2024-05-22 | Hughes-Wilson Alexandra See Remarks | Shares withheld for taxes | −24,918 | $1.01 | $25K | 7,650 |
| 2024-05-22 | Hughes-Wilson Alexandra See Remarks | Option exercise · Share Options (Right to buy) | −93,333 | $1.40 | $131K | 0 |
| 2024-05-22 | Hughes-Wilson Alexandra See Remarks | Option exercise · Share Options (Right to buy) | −75,000 | $1.01 | $76K | 0 |
| 2024-02-08 | Jenkins Annalisa Director | Grant or award · Share Options (Right to buy) | +45,000 | 45,000 |
Page 6 of 7 · 139 trades